Investors Obtain Approval Of $69M Settlement In Securities Fraud Class Action
OAKLAND, Calif. — A federal judge in California gave final approval to a $69 million settlement that ends a securities fraud class action brought by investors alleging that a biopharmaceutical company...To view the full article, register now.
Already a subscriber? Click here to view full article